General comments/chat, page-262

Hi Woody... I will throw in my thoughts for consideration, all that are IMO of course.

There still seems to be some miss-understood info regarding ADNs path.

Im not aware of another company on the ASX that is looking to process material as a feedstock for HPA (4N, 5N or otherwise). Therefore you cannot really compare ADN and its OPEX or CAPEX to other said coys. Our operation consist of DSO (stockpile to ship) and feedstock (crush, screen, dry).





As far as i can see, based on announcements, is that we are aiming to develop the business based on feedstocks, that is:-

1. DSO (~$150pt)
2. Kaolin (~$300pt)
3. Halloysite/Kaolin (~$500-$1000pt)
4. Halloysite ($3,000)




What our process design is based on, will be the impending test results from China and USA.

The exciting thing to me, that has transpired over the past few weeks is the additional business opportunity to manufacture a 4N HPA (~$30k-$35K) - as per below.

The above is VERY exciting, as the feedstock we can produce can be converted to a 4N HPA via a single purification stage, as apposed to multiple like peer companies.



So, im assuming China have tested this product, realised how cheap and quickly 4N HPA can be made, and now want to collaborate on a HPA plant in China? The good thing about this, is that the whole plant is based on our material. This gives us massive leverage to broker a favourable deal with minimal (if any) dilution. The other upside to this, i believe, is that this pathway would avoid US having to complete a SS, PFS, BFS etc, and raise CAPEX funds.


All the above is IMO..... im looking forward to another exciting week of info released